BlackRock Advisors’s Windtree Therapeutics WINT Stock Holding History
Bought
Maintained
Sold
Other funds holding WINT
SM
BBA
ARTA
BlackRock Advisors's WINT Position: Q4 2016 in Review
BlackRock Advisors held its Windtree Therapeutics (WINT) position steady in Q4 2016 at 2,806 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3655.
BlackRock Advisors first reported a position in WINT in Q2 2013 and has held it in 15 quarters since. The position peaked at $48K in Q1 2014. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.
- BlackRock Advisors held 2,806 shares of Windtree Therapeutics worth $4K as of Q4 2016.
- BlackRock Advisors left its Windtree Therapeutics share count unchanged in Q4 2016.
- Windtree Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3655 holding.
- BlackRock Advisors first reported a position in Windtree Therapeutics in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Windtree Therapeutics position peaked at $48K in Q1 2014.
- 31 funds tracked by Wall St. Rank held Windtree Therapeutics as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.